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The emergence of escape-mutants of Influenza Hemagglutinin following vaccination compels the yearly re-
formulation of flu vaccines. Since binding the sialic acid receptor remains in all cases essential for infection, small-
molecule inhibitors of hemagglutinin binding to sialic acid could be interesting therapeutic complements or 
alternatives to immuno-prophylaxis in the control of flu epidemics.  In this work, we made use of NMR 
spectroscopy to study the interaction between a derivative of sialic acid (the Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc 
trisaccharide) and hemagglutinins (H1 and H5) from human and avian strains of influenza virus, directly expressed 
on the surface of stable transfected 293T human cells. The hemagglutinins were shown to retain their native trimeric 
conformation and binding properties. Exploiting the magnetization transfer between the proteins and the ligand, we 
obtained evidence of the binding event and mapped the (non-identical) sugar epitopes recognized by the two 
hemagglutinin species. The rapid and reliable method for screening sialic acid-related hemagglutinin ligands we 











Influenza viruses are important respiratory pathogens causing significant morbidity, mortality and considerable 
economic losses in the recurrent yearly epidemics and much more devastatingly in the sporadic pandemic spreads. 
Influenza seasonal epidemics result in the death of 250,000 - 500,000 people every year (https://www.cdc.gov/flu), 
up to millions in specific pandemic years. Influenza viruses belong to the Ortomyxoviridae family and are formed by 
several genera: the most common being A, B and C. Most influenza serotypes are of avian origin. Although several 
of them have sporadically infected humans, only a few serotypes of influenza A virus (IAV) (bearing hemagglutinin 
variants H1, H2 and H3) have caused influenza pandemics in the last 100 years (Stevens et al., 2006a). Three viral 
surface proteins are embedded in the cell-derived virion membrane: hemagglutinin (HA), neuraminidase (NA) and 
the M2 proton channel protein. Based on the antigenicity of HA and NA, IAV can be further classified into different 
subtypes including 16 HA (H1–H16) and 9 NA (N1–N9) subtypes.  
M2 proton channel maintains pH across the viral envelope during cell entry and viral maturation. The first anti-
influenza virus drug, amantadine, is a specific blocker of the M2 H+ channel. Amantadin and its derivative have 
been widely abandoned due to virus resistance.  
HA binds to sialic-acid containing glycans on the surface of target cells. The binding triggers internalization of the 
virion into the host cell; NA releases the newly formed virus particles from an infected cell by nicking sialic acid 
residues to which the budding virion is bound (Skehel and Wiley, 2000; Xu et al, 2012).  
Based on structural studies of its highly conserved catalytic site (Colman et al, 1983; Varghese et al,1983), several 
competitive inhibitors of NA were developed. Two of them, oseltamivir (Tamiflu) and zanamivir (Relenza), have 
been approved worldwide as drugs. However, drug resistance due to the emergence of NA escape mutants is 
becoming widespread and the development of alternative anti-influenza drugs targeted to other components of the 
virus (including HA) are urgently needed (Jiang et al, 2010).  
To date, sialic acid-containing lipids and polymers have been studied as entry blockers (Matsubara et al, 2010). In 
particular, many types of sialic acid-containing polymers  have been developed on the basis of a cristallographyc HA 
structures, including sialic acid-conjugated dendritic polymers, sialyloligosaccharides containing poly L-glutamic 
acid backbones, and sialyllactose-carrying polystyrene (Gambaryan et al., 2005; Tanaka et al., 2014). Unfortunately 
they suffer from subtype-dependent antiviral activity and a low barrier for resistance selection (Tang et al., 2016). 
Taking into account these attempts, it is important the development of universal antagonists, which are able to bind 
into the sialic binding site with high affinity so that single protein mutations should not be able to escape their 
inhibition. In this context, the detailed analysis of the binding features of syalic derivatives is very important and in 
this paper a new procedure to perform the interaction studies will be proposed. 
The HA receptor glycans display a different glycosidic linkage between sialic acid -(Neu5Ac: N-acetyl neuraminic 
acid) and the penultimate sugar of the chain. Among these, influenza viruses recognize Neu5Ac(α2-3) or Neu5Ac 
(α2-6) linked to galactose (Gal) or N-acetyl galactosamine (GalNAc), (α2-6) linked to N-acetyl glucosamine 
(GlcNAc) containing oligosaccharides (Layne et al, 2009, Paulson et al., 2006). Until now, the general paradigm for 
the species selectivity of avian-and human-virus infection is that human-flu viruses preferentially bind to sialyl(α2-
6)-linked disaccharides that is predominant in the upper human respiratory tracts, whereas avian flu viruses bind to 
sialyl(α2-3)-linked disaccharide moieties of the host receptor binding sites, which predominates in the avian enteric 
tract (Paulson et al., 2006; Viswanathan et al., 2010) (Figure 1). The paradigm of classifying viruses as only 
sialyl(α2-3) or (α2-6) linkage types is not sufficient to explain the infection and transmission of various strains of 
avian and mammalian influenza viruses. In fact, in the case of H5N1, H7N9, and other mutated flu viruses, 
classification based on linkage specificity does not correlate with the tendencies of human infection and intra- and 
inter-species transmissions of flu viruses. For example, highly pathogenic H5N1 viruses show strong sialyl(α2-6)-
binding properties and weak sialyl(α2-3)-binding properties, but they have shown inefficient human infection and 
human-to-human transmission (Haselhorst et al, 2008; Chandrasekaran et al, 2008). 
To date, most efforts to study viral membrane proteins (HA and NA) have utilized solubilized versions of 
recombinant proteins (Elli et al., 2014), and there are concerns that the recombinant protein structure may not 
accurately reflect the native structure due to the absence of transmembrane domains or membrane components 
(Stevens et al, 2006b). Virus Like Particles (VLP) expressing HA have been used to overcome this problem 
(Haselhorst et al, 2008). VLP present the possibility to study the biochemical and biophysical properties of viral 
membrane proteins in their native environment, but they can contain significant amounts of serum proteins, which 
exhibit high potential for non-specific interactions, thereby complicating NMR studies of ligand-target interactions 
(Antanasijevic et al, 2016).  
In this paper we describe a new model system where HAs is expressed on the surface of stably transfected human 
HEK-293T cells. The expression of HAs at high density on the cell surface was confirmed by Fluorescence-
activated cell sorting (FACS) with anti-HA antibodies. The proteins were shown to be recognized by monoclonal 
antibodies specific for the native trimeric conformation and to maintain their  binding properties. The interaction of 
HA expressing HEK-293T cells with the Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc HA receptor  is demonstrated here 
for the first time, using STD-NMR experiments.  
We chose Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc trisaccharide (1) (Figure 1A) as target molecule to investigate the 
binding. The complex was analyzed by Saturation Transfer Difference (STD) NMR (Meyer and Peters, 2003), 
which is an ideal tool to map the epitope and to describe the target-ligand interactions (Vasile et al, 2014; 
Heggelund et al, 2012; Haselhorst et al, 2008). We have already shown that the interactions between small ligands 
and membrane-bound proteins can be observed by STD NMR and trNOESY techniques directly in suspensions of 
living cells (Potenza et al, 2011; Guzzetti et al, 2013 and 2017) or platelets (Potenza et al, 2008) without the need of 
isolating the protein receptor. These experimental conditions are particularly valuable in the case of membrane 
proteins, because the structural and thermodynamic features of purified proteins can differ  significantly from those 
attained in vivo.  
Figure 1.  
Results  
Characterization of H1- and H5-293T cell lines. 
Stable H1- and H5-transfectants of HEK-293T cells were constructed as detailed in the Methods. After transfection, 
HA-positive cells were sorted by FACS (Figure 2A.) The presence of HA DNA in the transfectants was monitored 
by PCR (Figure 2B). The proteins are exported to the cell surface as demonstrated by flow cytometry, which shows 
that more than 85% of the cells are HA-positive (Figure 2C). Western blot analysis of whole cell lysates in reducing 
and non-reducing conditions shows that the proteins are synthetized as monomers and then aggregated into dimers 
and trimers (Figure 2D). Immuno-precipitation with CR6261 of membrane proteins solubilized by Triton X-100 
extraction, followed by western blot analysis in non-reducing conditions, demonstrates that the surface proteins are 
correctly conformed as trimers and then dissociated into dimers and monomers during the electrophoresis (Figure 
2E). Furthermore, the HA molecules are shown to be able to bind sialic acid, because they agglutinate chicken red 
cells forming rosettes (Figure 2F). We repeated hemagglutination test on cells in buffer and we confirmed that HAs 
maintain their conformation after 15h (which are the NMR condition and experiments time), 
 Figure 2.  
Conformational analysis of the ligand 
The glycan conformation and topology is important in governing the receptor specificity of the human and avian  
hemagglutinin subtypes H1 and H5. The NMR spectra of 1 were measured in deuterated buffer solution and the 
assignment of compound is reported in Table I.  
The analysis of the conformational features of compound 1 at 298K has been made difficult by the absence of inter-
residual NOEs, due to high mobility of this small saccharide. At 283K,  the NOESY spectrum, recorded with 700 ms 
mixing time, shows one weak inter-residual NOE between H5 Neu5Ac and CH3CO GlcNAc corresponding to an 
estimated distance of 4-5 Å (Figure 1B). So we performed a molecular dynamic simulation and energy  
minimization with Gromacs.  Analyzing the resulting structures we observed that the molecule assume different 
conformations (Figure 1C): about 15% among these are satisfying the NMR constraint, indicating a bent 
conformation (Figure 1B).  
This kind of conformation (Figure 1B) is termed as “umbrella” in the literature and was reported for several 
derivatives with α(2-6) linkage at the nonreducing end, with different lengths and different second glicosidic 
linkages (Sassaki et al, 2013). This conformation is also reported (Chandrasekaran et al, 2008) for a tetrasaccharide 
cocrystallized with a human HA subtype, in which the mobility of the backbone of the ligand allows it to explore 
conformations similar to an umbrella progressing from a fully open form to a fully closed form. 
The tr-NOESY experiment (data not shown) in presence of transfected cells has few and weak NOE cross peaks 
similar to that observed in the NOESY experiment of the free ligand. The absence of inter-residual NOEs does not 
allow us to identify a preferred bound conformation and not even a significant conformational change upon binding 
to the protein. 
NMR Interaction studies 
Making use of STD-NMR technique, we analyzed the interaction of 6’-α-sialyl-N-acetyllactosamine (1) with three 
different cell lines: H1-293T and H5-293T, stably transfected with human (H1) and aviary (H5) hemagglutinin 
genes, respectively, and untransfected 293T cells as a negative control (Figure 3). The use of STD technique permits 
to obtain  evidence of binding and information about the protons involved in the epitope. 
No binding evidence was obtained in the experiment with control cell line (untransfected 293T), while,on the 
contrary, clear STD signals are shown for the trisaccharide in the presence of both HA-expressing cell lines (Figure 
3). The absence of signal in control experiments suggests that we are observing a specific binding of the ligand to 
HAs.The spectra also show that the binding epitopes of the saccharide differ in presence of the two HAs.  
Figure 3.  
For a better comparison of the epitope of the molecule 1 with different HA subtypes, atoms interacting with H1-
293T cells are labelled with red dots in Figure 4A, while those involved in the interaction with H5-293T cells are 
marked with blue dots in Figure 4B. Absolute STD % (Meyer and Peters, 2003) were quantified and reported in 
Figure 4C-D. 
Figure 4.  
The analysis of the ligand in presence of cells expressing H1 suggests that the epitope (Figure 4A) comprises the 
acetyl group and H7 of the Neu5Ac mojety, the anomeric and H2 protons of Gal and only the acetyl group of 
GlcNAc. All the saccharides have protons interacting with the protein, but it is a quite shallow interaction with low 
values of absolute STD percentage (ranging from 0.36% for H2 Gal and H7 NeuAc, to 0.68% for Acetyl groups, 
Figure 4C). This epitope is compatible with the interactions suggested in the literature for similar compounds (i.e. 
PDB structure 2WRG, Liu et al, 2009) and H1 hemagglutinin. 
The same ligand in presence of cells expressing H5 exhibits a different epitope. Several peaks of  Neu5Ac mojety 
can be detected in STD experiment (Figure 3 and 4B), such as the acetyl group, and the H3, H5, H6, H7 and H8 
protons, suggesting that it is more strongly involved in the interaction with the target HA-H5. Also the GlcNAc 
interaction is more effective involving the acetyl group, the anomeric and H2 protons. Also in this case, H1 and H2 
protons of Gal residue contribute to epitope. In this case the number of protons involved in the epitope and the 
absolute STD percentage (Figure 4D) of signals (ranging from 1.6% for H2 Gal and H7 NeuAc, to 2.8% for Acetyl 
groups) suggest a stronger interaction of the ligand with a particular involvement of the sialyl group. 
A strong interaction of Acetyl groups and a weak involvment of the Galactose residue are common point with both 
cell lines. These results recapitulate the known features of the sialyl(α2-6) derivatives. In particular, the binding 
mode observed by X-ray in presence of H1 (Liu et al, 2009) and the strongest affinity of short α2-6 saccharides for 
H5 subtype  (Chandrasekaran et al., 2008). Our data also confirm that: i) hemagglutinin is expressed in its 
native/active conformation on the HEK cell membrane and ii) that these cells are good tools for rapid screening and 
structural optimization of HA antagonists. 
Discussion 
The rapid genomic variability of the influenza virus requires a continuous effort in the development of anti-viral 
molecules, to circumvent the emergence of resistant strains. A key tool for the rational design of such anti-viral 
leads is STD-NMR, which can map the interactions of the epitope as a function of variation of the target molecule at 
atomic scale. In this paper, we developed a rapid and reliable new method for screening sialic acid-related 
hemagglutinin ligands in an environment which is much more similar to that in vivo than using the purified protein 
or the popular VLP.  
We tested the method to analyze the interaction of sialyl trisaccharide 1 with 293T cells transfected with H1 and H5 
subtypes of hemagglutinin, responsible for human and bird flu respectively. The key feature provided by this 
method is that HA molecules transfected on HEK-293T cells membrane retain their native conformations (as 
evidenced by the reactivity with monoclonal antibodies specific for conformational stem epitopes) and  their binding 
properties (evidenced by the rosettes formed with chicken erythrocytes). With this approach, we are able to detect 
the binding event and the epitope, both valuable informations for drug design and we suggest that this could be a 
suitable effective method to screen other ligands which might act as antagonists of possible pharmacological 
relevance. Three different cell lines (untransfected 293T, H1-293T and H5-293T), suspended in phosphate buffer, 
were tested to produce control STD-NMR spectra, suggesting that no subtraction is necessary. This is a remarkable 
improvement over the use of VLPs, which produced noise signals from nonbinding ligands (i.e. unavoidable 
medium components) (Haselhorst et al, 2008). The absence of cells residual effect makes the STD signals clearer 
and easily detectable.  
Making use of STD-NMR spectra of Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc in presence of human H1 and avian H5 
we could rationalize at atomic level the different binding properties to the two strains. Currently, avian H5N1 
viruses have high α2-3 glycan specificity but some strains  also show mixed α2-3 /α2-6 binding (Yamada et al., 
2006 ), but have not yet transmitted between humans at epidemic levels. Recent studies based on analysis of HA–
glycan cocrystal structures (Bewley, 2008; Chandrasekaran et al, 2008) have highlighted the importance of glycan 
conformation and topology in governing the receptor specificity of avian- and human-adapted HAs. Our results 
suggested that α2-6 human receptor is able to bind avian H5 with a wider epitope  relative to human H1. In fact, in 
presence of H5, the Neu5Ac residue at the nonreducing end is strongly involved in the interaction. These data are in 
agreement with the observation, reported by Chandrasekaran et al., that also avian viruses are able to bind α2-6 
saccharides, since they conclude that human adapted viruses (H1)  may be able to bind long (α2-6) derivatives 
preferentially while avian viruses (H5) bind (α2-3) and short (α2-6) saccharides. 
We think that further applications of this studies can bring to a better understanding of HAs – glycans binding 
features and can be useful for the design of new anti-influenza drugs.  
Materials and Methods 
Compound Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc was purchased by Carbosynth Ltd, Berkshire (UK).  
Construction of stable hemagglutinin-expressing transfectant cell lines 
Constructs pcDNA3.1-H1 and pcDNA3.1-H5 plasmids, carrying the hemagglutinin genes from influenza viruses 
A/California/7/2009_H1N1 and A/Cygnus olor/Italy/724/2005_H5N1, were obtained by subcloning the genes (Di 
Lullo et al., 2009) into the MCS of the commercial plasmid pcDNA3.1(+) (Invitrogen), in which gene expression is 
dierected by the CMV promoter. The human cell line HEK-293T (ATCC CRL-3216) was transfected with plasmid 
DNA (10 µg/ml. Transfectants were selected in G418-containing medium and passaged 3 times in the same 
medium. HA-transfectants show unaffected growth rate and mortality as compared to untransfected HEK-293T. 
Cells expressing HA on the cell surface were sorted (by FACS) with anti-HA stem monoclonal antibody CR6261 
(Friesen et al., 2010) (Acrobiosystems, USA), specific for the native conformation, and expanded as the stable 
transfectant cell lines H1-293T and H5-293T. PCR (with serotype-specific primers), Western blot (in reducing 
conditions, with chicken anti-HA antisera), flow cytometry (with CR6261), immuno-precipitation with CR6261 
(followed by western blot analysis in non-reducing conditions) were carried out by standard methods. For the 
hemagglutination rosette assay with chicken erythrocytes (ChRBC), H1-293T, H5-293T, or untransfected 293T cells 
were mixed with ChRBC, spun into a pellet, resuspended and spun through a Histopaque cushion (293T cells float 
on Histopaque-1.077 (Sigma-Aldrich), while ChRBC form a pellet).  HA-dependent 293T rosettes were recovered 
from the red pellet. 
NMR experiments 
All NMR spectra were registered on Bruker Avance 600 MHz using 7–9 mM solutions of the ligand in deuterated 
phosphate buffer (pH 7.4). The assignment was performed through one- and two-dimensional 1H and 13C NMR 
spectra by standard manual method (Wuthrich, 1986; Vasile et al, 2008). The complete assignment of the molecule 
is reported in Table I. The proton resonances did not show significant shifts when the compound was analyzed in the 
presence of the cells suspension. For the conformational analysis, we recorded NOESY with 700 ms and tr-NOESY 
with 200 ms mixing time. 1H and NOESY experiments were performed using an excitation sculpting sequence for 
solvent suppression. The STD–NMR spectra were acquired in the presence of about 10x106 T293 untransfected and 
transfected cells in a total volume of 200 mL, using the Watergate sequence for water suppression and varying the 
saturation times from 0.98 to 2.94 s. The on-resonance irradiation of the protein was performed at a chemical shift of 
-0.05 ppm. Off-resonance irradiation was applied at 200 ppm, where no protein signals were visible. Negative 
controls were performed to avoid the presence of signals in the blank or artifacts. STD spectra of the free ligands 
and of the cells in absence of ligand did not show any signals. Velocity of sedimentation of the cells in the NMR 
tube was not studied but the cells are maintained in suspension thanks to the rotation into the NMR probe(the spin 
rate is 20 revolutions/second = 20 Hz).  
NMR experiments were acquired at 298 K and repeated at 283K on free ligand in order to reduce the mobility and to 
observe NOEs useful for conformational analysis. At 298 K, due to the high mobility of this small saccharide,  we 
detected only an intra-residual NOE (NeuAc H3eq/H3ax), at 283K instead we detected several intra-residual NOEs 
(NeuAc H3eq/H3ax, NeuAc H3eq/H4, NeuAc H5/H3ax, Gal H1/H3) and one inter-residual NOE (NeuAc H5/ 
GlcNAc COCH3) and we used it for the conformational analysis. 
STD experiments were performed at 298K and also in this case they were repeated at 283K as attempt to slow down 
the magnetization exchange and to obtain an enhancement of the signals.  The STD experiments discussed herein 
were conducted at 298 K with a total irradiation time of 2.94 s.  
Conformational analysis 
The molecular dynamic simulations are performed with Gromacs 4.6.5 (Hess et al, 2008). The interactions of the 
molecule are modelled with the GAFF force field (Wang et al, 2004, Vasile et al, 2017) in explicit water. After 
energy minimization and water thermalisation, we performed 50ns of simulation at 300K, recording 1000 
conformations to be analyzed. 
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Figure 1. Structure of Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc  1 (A). Representative structure of the bent 
conformation in which the distance between NeuAc H5/ GlcNAc COCH3 is lower than 0.5 nm, compatible with the 
presence of the NOE (the population of this family of structure is estimated around 15%)  (B). Representative 
structure of a more extended conformation (C).   
Figure 2. (A) Fluorescence-Activated Cell Sorting with Mab CR6261 of H1- and H5-transfectants of HEre collected 
from “R4” sorting windows. (B) PCR analyis of HA DNA from H1-293T and H5-293T cell lines; subtype-specific 
primers reveal a short internal fragment of the H1 gene and a full-length fragment of the H5 gene. Positive and 
negative controls (C+ an C-) are the donor plasmids and untransfected 293T cells, respectively. (C) Flow cytometry 
analysis, with Mab CR6261, shows that more than 85% of the cells are HA-positive in both cell lines. (D) Western 
blot analysis of whole cell lysates, in reducing (+DTT) and non-reducing (-DTT) conditions, shows that the proteins 
are synthetised as monomers and aggregated into dimers and trimers. (E) Immuno-precipitation with CR6261 of 
membrane proteins solubilized by Triton X-100 extraction, followed by western blot analysis in non-reducing 
conditions. (F) H5-293T cells (and H1-293T cells, not shown) agglutinate chicken red cells forming rosettes. 
Figure 3. A) 1H-NMR of 6’-α-sialyl-N-acetyllactosamine in deuterated phosphate buffer pH=7.4 (T=298K).  B and 
C) STD-NMR experiments of 6’-α-sialyl-N-acetyllactosamine  in presence of H5-293T and H1-293T cells 
respectively. D) STD-NMR experiments of 6’-α-sialyl-N-acetyllactosamine  in presence of untransfected cells. 
NMR experiments were performed using a Bruker 600 MHz spectrometer, STD spectra were obtained with - 0.05 
ppm as irradiation frequency and 2.94 s of saturation time.  
Figure 4. The protons belonging to the epitope of compound 1 in the presence of H1-293T  cells are marked with 
dots (A) and the absolute STD percentage for each protons is reported  (C). The same compound analyzed in 
presence of H5-293T  shows a stronger affinity: the epitope comprises several protons (B) with a higher intensity of 
absolute STD % (D). 
  
Table I. NMR assignment of Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc in deuterated phosphate buffer (pH=7.4). 
 
NeuAc 
 1H (ppm)* 13C (ppm) 
3  2.58 (eq), 1.63 (ax) 39.4 
4 3.56 67.5 
5 3.74 54.9 
6 3.62 71.6 
7 3.48 67.6 
8 3.89 69.0 
9 3.79, 3.56 61.9 
CH3 1.94 21.8 
Gal 1 4.36 102.6 
2 3.46 70.0 
3 3.6 71.8 
4 3.84 67.9 
5 3.74 72.9 
6 3.91, 3.46 62.8 
GlcNAc (α) 1 5.12 89.7 
2 3.85 52.6 
3 3.81 70.9 
4 3.58 80.2 
5 3.54 73.9 
6 3.79 59.3 
CH3 1.98 22.0 
GlcNAc (β) 1 4.66 94.0 
2 3.64 55.3 
3 3.81 70.9 
4 3.58 80.2 
5 3.54 73.9 
6 3.83, 3.73 59.6 
CH3 1.98 22.0 
* The spectrum is referenced through the solvent lock (2H) signal according to IUPAC recommended secondary 
referencing method. 
